- Trials with a EudraCT protocol (67)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (30)
67 result(s) found for: Thyroxine.
Displaying page 1 of 4.
EudraCT Number: 2014-000574-19 | Sponsor Protocol Number: LT4RAIT | Start Date*: 2014-03-24 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERO-UNIVERSITARIA DI PARMA | |||||||||||||
Full Title: Experimental study for the evaluation of the effect of radioactive iodine therapy on free thyroxine circulating levels after oral administration of sodium levo-thyroxine in patients thyroidectomiz... | |||||||||||||
Medical condition: patients thyroidectomized for differentiated thyroid cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021228-89 | Sponsor Protocol Number: CICO-10-01 | Start Date*: 2011-04-22 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: Effect of L-Thyroxine supplementation in the first weeks of life on long-term neurodevelopmental outcome in infants with transient hypothyroxinemia born at or less than 28 weeks’ gestation | |||||||||||||
Medical condition: infants with transient hypothyroxinemia born at or less than 28 weeks’ gestation | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-005184-15 | Sponsor Protocol Number: 05_ENDO_46 | Start Date*: 2005-05-24 |
Sponsor Name:Christie Hospital NHS Trust | ||
Full Title: Central Hypothyroidism and Adjusted Thyroxine dose Study (CHATS): impact of increasing free thyroxine levels in patients with hypopituitarism | ||
Medical condition: Central (secondary/tertiary) hypothyroidism (subclinical) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-023918-30 | Sponsor Protocol Number: SOMA-001-2010 | Start Date*: 2011-03-16 | |||||||||||
Sponsor Name:SOCIETA' ITALO BRITANNICA L. MANETTI - H.ROBERTS & C. PER AZIONI | |||||||||||||
Full Title: Pilot clinical study on the systemic bioavailability of l-thyroxine in healthy female volunteers after four weeks of topical treatment with a new formulation based on l-thyroxine | |||||||||||||
Medical condition: treatment of localized fat, accompanied by cellulite | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003464-30 | Sponsor Protocol Number: CTHS02 | Start Date*: 2005-09-08 |
Sponsor Name:Queen Mary, University of London | ||
Full Title: Double blind randomised cross-over trial to assess the value of screening an adult population for hypothyroidism | ||
Medical condition: Hypothyroidism. People with high thyroid stimulating hormone (TSH) serum level with normal or low free thyroxine. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-001248-12 | Sponsor Protocol Number: THYR69 | Start Date*: 2015-10-30 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERO-UNIVERSITARIA MEYER | |||||||||||||
Full Title: Randomized crossover trial for the evaluation of the possible effects in the intestine of two different pharmaceutical forms of L - Thyroxine in patients with primary acquired hypothyroidism | |||||||||||||
Medical condition: Primary acquired hypothyroidism | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023509-37 | Sponsor Protocol Number: IIT2010 | Start Date*: 2011-06-29 |
Sponsor Name:Institut für klinische Forschung und Entwicklung Berlin GmbH am St. Hedwig Krankenhaus | ||
Full Title: A prospective, randomized, single-blind, placebo-controlled, two-armed, phase IV study in patients with subclinical hypothyroidism treated over 52 weeks either with levothyroxine in adjusted dosing... | ||
Medical condition: Subclinical hypothyroidism | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-005732-28 | Sponsor Protocol Number: LE-9999-401-BE | Start Date*: 2013-06-14 | ||||||||||||||||
Sponsor Name:Takeda Belgium | ||||||||||||||||||
Full Title: A multicentre, open-label switch study to investigate the necessity of dose adjustment after switching from L-Thyroxine Christiaens® to the new levothyroxine sodium test formulation in (near) total... | ||||||||||||||||||
Medical condition: Patient that underwent a near total thyroidectomy and therefore are compelled to take levothyroxine hormone substition therapy. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-001369-28 | Sponsor Protocol Number: 880 | Start Date*: 2014-10-30 | |||||||||||
Sponsor Name:Gateshead Health NHS Foundation Trust | |||||||||||||
Full Title: THYRoxine in Acute Myocardial Infarction (ThyrAMI) | |||||||||||||
Medical condition: Hypothyroidism and Acute Myocardial Infarction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002614-36 | Sponsor Protocol Number: 05ICHF/T407 | Start Date*: 2007-04-20 | |||||||||||
Sponsor Name:IBSA | |||||||||||||
Full Title: Multicentre, controlled, randomised, open-label, cross-over clinical study of the efficacy and tolerability of L-thyroxine T4 soft capsules, in comparison to L-thyroxine tablets, in thyroidectomi... | |||||||||||||
Medical condition: Substitutive and/or TSH suppressive therapy in thyroidectomized patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004876-20 | Sponsor Protocol Number: GRAV12 | Start Date*: 2012-11-13 | |||||||||||
Sponsor Name:FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO | |||||||||||||
Full Title: Study on the effectiveness of two different formulations of L-thyroxine compress and liquid oral solution) in pregnant patients affected with hypothyroidism. | |||||||||||||
Medical condition: Hypothyroidism in pregnant patients | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004136-38 | Sponsor Protocol Number: LEVOSOFT_2016 | Start Date*: 2018-07-26 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA UNIVERSITARIA SENESE | |||||||||||||
Full Title: PROSPECTIC, RANDOMIZED, NATIONAL MULTICENTRIC STUDY, FINALIZED TO ASSESS THE STABILITY OF TSH LEVELS IN THYROIDECTOMISED PATIENTS IN THERAPY WITH TWO FORMULATIONS OF LEVOTYROXIN (TABLETS AND SOFT-GEL) | |||||||||||||
Medical condition: IATROGENIC HYPOTHYROIDISM IN THYROIDECTOMIZED PATIENTS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-005242-21 | Sponsor Protocol Number: 07_ENDO_66 | Start Date*: 2008-05-07 |
Sponsor Name:THE CHRISTIE NHS FOUNDATION TRUST | ||
Full Title: A pilot study of replacement therapy with recombinant TSH in central hypothyroidism | ||
Medical condition: Central Hypothyroidism which is due to deficiency of TSH caused by the disease, surgery or radiotherapy of the pituitary gland. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-003099-39 | Sponsor Protocol Number: LWH0604 | Start Date*: 2008-08-21 |
Sponsor Name:Liverpool Women's NHS Foundation Trust Hospital | ||
Full Title: A Randomised Controlled Trial of Thyroxine in Preterm Infants Under 28 weeks' Gestation. | ||
Medical condition: Hypothyroidism is a condition where there is a lack of thyroid hormone in the body. Thyroid hormones are important for normal brain development and growth. Children who are born with low thyroid ho... | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-001696-21 | Sponsor Protocol Number: AOBS-2MED-TICO-2013 | Start Date*: 2013-08-20 |
Sponsor Name:AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA | ||
Full Title: Prospective blinded study of the absorption of levothyroxine oral solution (Tirosint ® single-dose oral solution) in patients with hypothyroidism. | ||
Medical condition: Hypothyrodism | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-001681-25 | Sponsor Protocol Number: 23681 | Start Date*: 2015-07-15 |
Sponsor Name:Merck KGaA | ||
Full Title: An Open, Multicenter, Randomized, Controlled Trial to Evaluate the Correlation Between Spontaneous Catch-up Growth, Clinical Response to Saizen (Recombinant Human Growth Hormone, r-hGH) and Gene Ex... | ||
Medical condition: Small for Gestational Age | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2013-004090-28 | Sponsor Protocol Number: Fx-R-001-S1/B3461049 | Start Date*: 2014-05-13 |
Sponsor Name:Fold RX Pharmaceuticals, a Pfizer Company | ||
Full Title: TRANSTHYRETIN-ASSOCIATED AMYLOIDOSES OUTCOMES SURVEY (THAOS) – OPTIONAL BLOOD SAMPLE COLLECTION SUBSTUDY | ||
Medical condition: Transthyretin (TTR) a 127-amino acid, tetrameric protein, primarily synthesized in the liver, is a secreted protein present in the blood and cerebrospinal fluid and is a carrier of thyroxine and r... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-003673-34 | Sponsor Protocol Number: BioCellThyr | Start Date*: 2018-04-05 |
Sponsor Name:Oslo University Hospital, Department of Endocrinologi, Morbid Obesity and Preventive Medicine | ||
Full Title: Identification of non-responders to levothyroxine-therapy: development of biomarkers reflecting T4 and T3 action at the tissue level | ||
Medical condition: Women with dysregulated hypothyroidism | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-023783-41 | Sponsor Protocol Number: E7080-G000-303 | Start Date*: 2011-07-05 | |||||||||||
Sponsor Name:Eisai Limited | |||||||||||||
Full Title: A Multicenter, Randomized, Double- Blind, Placebo-Controlled, Phase 3 Trial of Lenvatinib (E7080) in 131I- Refractory Differentiated Thyroid Cancer | |||||||||||||
Medical condition: 131I-refractory differentiated thyroid cancer (DTC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) CZ (Completed) PT (Completed) GB (Completed) DE (Completed) ES (Completed) PL (Completed) DK (Completed) AT (Completed) IT (Completed) SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004451-35 | Sponsor Protocol Number: MRTSH01505 | Start Date*: 2007-03-13 | |||||||||||
Sponsor Name:Genzyme Europe BV | |||||||||||||
Full Title: Study to Evaluate the Dose, Safety and Effectiveness of Modified-Release Recombinant Human Thyroid Stimulating Hormone (MRrhTSH) When Used in Conjunction with Radioiodine for the Treatment of Multi... | |||||||||||||
Medical condition: Nodular goiter are clinically recognizable enlargements of the thyroid gland characterized by excessive growth and structural and or functional transformation of one or several areas within the nor... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) DK (Completed) FR (Completed) DE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
